TC BioPharm Ltd (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TCBP Nasdaq 8731 https://tcbiopharm.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TC BioPharm Ltd (ADR)

TC BioPharm to Present at LD Micro Invitational XIII Conference on June 7, 2023 - May 24th, 2023 1:00 pm
TC Biopharm (Holdings) Full Year 2022 Earnings: Beats Expectations - May 4th, 2023 10:29 am
TC BioPharm Increases Allogeneic Car and Partnering Focus for Advancement of TCB-008 - Apr 26th, 2023 12:30 pm
TC BioPharm to Present at the Sequire Investor Summit in Puerto Rico - Apr 19th, 2023 12:00 pm
TC BioPharm Announces Closing of $5.5 Million Public Offering - Mar 30th, 2023 8:15 pm
TC BioPharm Announces Pricing of $5.5 Million Public Offering - Mar 28th, 2023 12:05 pm
TC Biopharm Announces Corporate Restructuring, Reduction in Overhead - Mar 22nd, 2023 12:30 pm
TC BioPharm Receives Extension from Nasdaq Hearings Panel to Regain Compliance With Listing Rule 5550(b)(2) - Mar 16th, 2023 4:00 pm
TC BioPharm Shifts Focus to FDA Clinical Trials - Mar 7th, 2023 1:30 pm
TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer - Feb 23rd, 2023 1:30 pm
TC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell Therapies - Feb 21st, 2023 1:30 pm
TC BioPharm Announces New Chair of the Board, Arlene Morris - Feb 14th, 2023 1:30 pm
TC BioPharm to Reschedule Shareholder Update Call and Webcast - Feb 13th, 2023 9:15 pm
TC BioPharm Announces Successful Dosing of Final Patient in ACHIEVE Safety Cohort - Feb 7th, 2023 1:30 pm
TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division - Jan 30th, 2023 1:30 pm
TC BioPharm to Host Shareholder Update Call - Jan 20th, 2023 1:30 pm
TC BioPharm Receives Notice of Non-compliance with NASDAQ's Listing Rule 5550(b)(1) - Jan 19th, 2023 1:30 pm
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology - Jan 17th, 2023 1:30 pm
TC BioPharm Reports First Half 2022 Financial Results and Provides Shareholder Update - Dec 12th, 2022 2:00 pm
TC BioPharm Announces Closing of $7.35 Million Private Placement - Nov 30th, 2022 11:43 pm